Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54
Closed -$5.45K 715
2025
Q4
$5.45K Sell
54
-9
-14% -$977 ﹤0.01% 366
2025
Q3
$7.77K Sell
63
-66
-51% -$8.19K ﹤0.01% 345
2025
Q2
$15.5K Buy
129
+95
+279% +$12.7K 0.01% 239
2025
Q1
$5.01K Buy
34
+8
+31% +$1.22K ﹤0.01% 331
2024
Q4
$4.22K Hold
26
﹤0.01% 387
2024
Q3
$4.24K Hold
26
﹤0.01% 370
2024
Q2
$3.55K Buy
26
+7
+37% +$972 ﹤0.01% 388
2024
Q1
$2.91K Hold
19
﹤0.01% 415
2023
Q4
$2.71K Buy
+19
New +$2.53K ﹤0.01% 404

Other funds holding CLX

Aspect Partners's CLX Position: Q1 2026 in Review

Aspect Partners sold out of Clorox (CLX) in Q1 2026, closing a stake of 54 shares — an estimated $5.45K sold.

Aspect Partners first reported a position in CLX in Q4 2023 and held it in 9 quarters. The position peaked at $15.5K in Q2 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Aspect Partners reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Aspect Partners sold 54 Clorox shares in Q1 2026, an estimated $5.45K.
  • Aspect Partners first reported a position in Clorox in Q4 2023 and held it in 9 quarters.
  • Aspect Partners's Clorox position peaked at $15.5K in Q2 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Aspect Partners's 13F filing for Q1 2026, filed 2 Apr 2026.